First-line treatment in senior adults with metastatic castration-resistant prostate cancer: A prospective international registry

Droz, Jean-Pierre; Efstathiou, Eleni; Yildirim, Asif; Cabrera, Paula; Kim, Choung; Horchani, Ali; Heidenreich, Axel; Rinck-Junior, Jose; Hitier, Simon; Ozen, Haluk

doi:10.1016/j.urolonc.2015.12.005

First-line treatment in senior adults with metastatic castration-resistant prostate cancer: A prospective international registry

Droz J., Efstathiou E., Yildirim A., Cabrera P., Kim C. S., Horchani A., ...More

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, vol.34, no.5, 2016 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 34 Issue: 5
Publication Date: 2016
Doi Number: 10.1016/j.urolonc.2015.12.005
Journal Name: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Hacettepe University Affiliated: Yes

Abstract

Aims: To compare the efficacy and tolerability of taxane and nontaxane therapy in senior adults with chemonaive metastatic castration resistant prostate cancer (mCRPC), and examine the effect of patient health status on outcomes.